ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,644,000 | +29.2% | 9,554 | -5.7% | 0.01% | +40.0% |
| Q2 2021 | $1,272,000 | +0.1% | 10,135 | +8.1% | 0.01% | -79.2% |
| Q1 2021 | $1,271,000 | -2.2% | 9,373 | -7.8% | 0.05% | -2.0% |
| Q4 2020 | $1,300,000 | +13.7% | 10,161 | 0.0% | 0.05% | -2.0% |
| Q3 2020 | $1,143,000 | +29.2% | 10,161 | +9.4% | 0.05% | +22.0% |
| Q2 2020 | $885,000 | +26.4% | 9,290 | +19.2% | 0.04% | +141.2% |
| Q1 2020 | $700,000 | +65.1% | 7,792 | -2.5% | 0.02% | +112.5% |
| Q4 2019 | $424,000 | +38.6% | 7,991 | +3.2% | 0.01% | +33.3% |
| Q3 2019 | $306,000 | -5.3% | 7,746 | -1.4% | 0.01% | -25.0% |
| Q2 2019 | $323,000 | +11.8% | 7,854 | +26.6% | 0.01% | +14.3% |
| Q1 2019 | $289,000 | +19.4% | 6,205 | +11.7% | 0.01% | 0.0% |
| Q4 2018 | $242,000 | -13.9% | 5,556 | -4.1% | 0.01% | 0.0% |
| Q2 2018 | $281,000 | +29.5% | 5,795 | +13.5% | 0.01% | +16.7% |
| Q4 2017 | $217,000 | – | 5,107 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |